2024/03/28 08:08:16 | |
---|---|
Price | |
0.3529 EUR | |
Difference | 0.80% (0.00) |
ISIN | KYG8167W1380 |
Symbol | 1177 |
Exchange | Berlin |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 6,568 EUR |
Benchmark | HANG SENG INDEX |
Bid (Bid size) | 0.3376 EUR (14,383) |
Ask (Ask size) | 0.3576 EUR (13,601) |
Open | 0.3529 EUR |
High | 0.3529 EUR |
Low | 0.3529 EUR |
Close (prev. day) | 0.3501 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 1 |
Last size | 0 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/03/13 | Global Equity Ratings | ||
2024/02/22 | Global Equity Ratings | ||
2024/02/14 | Global Equity Ratings | ||
2024/01/23 | Global Equity Ratings | ||
2023/12/21 | Global Equity Ratings |
2024/03/28 08:08:16 | |
---|---|
Price | |
0.3529 EUR | |
Difference | 0.80% (0.00) |
ISIN | KYG8167W1380 |
Symbol | 1177 |
Exchange | Berlin |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 6,568 EUR |
Benchmark | HANG SENG INDEX |
Bid (Bid size) | 0.3376 EUR (14,383) |
Ask (Ask size) | 0.3576 EUR (13,601) |
Open | 0.3529 EUR |
High | 0.3529 EUR |
Low | 0.3529 EUR |
Close (prev. day) | 0.3501 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 1 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | +3.49% | -31.19% | -59.05% |
Perf (abs.) | +0.01 | -0.16 | -0.50 |
Beta | - | 2.66 | 1.10 |
Volatility | 48.74 | 41.57 | 40.70 |
Ø price 5 days | Ø volume 5 days (pcs.) | 0.3575 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 0.3583 EUR (327) |
Ø price 100 days | Ø volume 100 days (pcs.) | 0.3737 EUR (132) |
Ø price 250 days | Ø volume 250 days (pcs.) | 0.3882 EUR (97) |
YTD High | date | 0.3895 EUR (2024/01/10) |
YTD Low | date | 0.3232 EUR (2024/02/05) |
52 Weeks High | date | 0.5270 EUR (2023/04/18) |
52 Weeks Low | date | 0.2991 EUR (2023/10/23) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Tradegate | 2024/03/27 | 22:26 | 0.3471 EUR | 0.01 | 4 |
Stuttgart | 2024/03/28 | 08:15 | 0.3524 EUR | 0.00 | 1 |
Munich | 2024/03/28 | 08:16 | 0.3647 EUR | 0.00 | 1 |
Hong Kong Stock Exchange | 2024/03/28 | 09:08 | 3.02 HKD | - | - |
Hanover | 2024/03/28 | 08:11 | 0.3529 EUR | 0.00 | 1 |
Frankfurt | 2024/03/28 | 08:09 | 0.3529 EUR | 0.00 | 1 |
FINRA other OTC Issues | 2024/03/27 | 15:53 | 0.3473 USD | 0.00 | 1 |
Duesseldorf | 2024/03/28 | 12:30 | 0.3459 EUR | 0.00 | 3 |
Berlin | 2024/03/28 | 08:08 | 0.3529 EUR | 0.00 | 1 |
BX Swiss | - | - | - | 0.00 | - |
SINO BIOPHARMACEUTICAL LTD. |
- - |
Unit 09, 41st Floor, Office Tower, Convention Plaza - - Hong Kong |
Telefon: +852-2802-9886 |
Fax: +852-2880-0847 |
E-mail: info@sino-biopharm.com |
Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. It operates through the following business segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The Modernised Chinese Medicines and Chemical Medicines segment comprises the manufacturing, selling, and distribution of modernized Chinese medicine products and western medicine products. The Investment segment offers long term investments. The Other segment includes a research and development sector, which provides services to third-parties; and related healthcare and hospital business. It also develops medicines for treating tumors, analgesia, diabetes, and respiratory system diseases. The company was founded by Ping Tse on February 2, 2000 and is headquartered in Hong Kong. |
Li Yi | Chairman of Managing Board |
Cheng Cheung Ling | Member of Executive Committee |
Li Mingqin | Member of Executive Committee |
Theresa Tse | Member of Executive Committee |
Tian Zhoushan | Member of Executive Committee |
Tse Hsin | Member of Executive Committee |
Tse Ping | Member of Executive Committee |
Tse, Eric | Member of Executive Committee |
Wang Shanchun | Member of Executive Committee |
Theresa Tse | Chairman of Supervisory Board |
Kwok Tung Li | Member of Supervisory Board |
Zheng Fei Lu | Member of Supervisory Board |
Cheung Ling Cheng | Member of Supervisory Board |
Da Kui Li | Member of Supervisory Board |
Hong Lu | Member of Supervisory Board |
Hsin Tse | Member of Supervisory Board |
Lu Fu Zhang | Member of Supervisory Board |
Ming Qin Li | Member of Supervisory Board |
Ping Tse | Member of Supervisory Board |
Zhou Shan Tian | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer